Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study
Authors' conclusion
Facilitators towards vaccination were more important than barriers. Most barriers against vaccination were intrapersonal issues.
Study context
- Population
- Consecutive patients with rheumatic musculoskeletal diseases (RMD), February–April 2021
- Participants
- 441 questionnaire respondents
- Outcome
- Facilitators and barriers towards vaccination in general and against pneumococci, influenza and SARS-CoV-2
Methodological detailsstructured questionnaire, consecutive patients
- Structured questionnaire
- Consecutive patients
Main finding
As reported in the abstract
Knowledge about vaccination decent
≥70% of patients
Doubted effectiveness of vaccination
<10% of patients
Observational data: associations, not effects.
Original publication
Facilitators and barriers for vaccination in patients with inflammatory rheumatic musculoskeletal diseases: a prospective cohort study. RMD Open. Published 9 June 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →